Compare Efficacy of Oxytocin Administrations on Postpartum Uterine

Updated 06/21/2024

Status Terminated

Clinical Trial Summary

This is a Phase I open-label, parallel-group clinical study in healthy term pregnant females undergoing a caesarean section. Two administrations of oxytocin will be tested, after which uterine contractility will be assessed.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02908126
Study type	Interventional
Source	Oxytone Bioscience BV
Contact
Status	Terminated
Phase	Phase 1
Start date	April 3, 2018
Completion date	June 27, 2019

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT02303418` - Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Undergoing Caesarean Sections for Placenta Previa: A Randomised Controlled Trial	Phase 3
	Recruiting	`NCT00344929` - Severe Post Partum Haemorrhage (PPH): A Randomized Trial on Transversal Intervention in 6 French Perinatal Networks	N/A
	Not yet recruiting	`NCT05336838` - Improving Management of Post-partum Haemorrhage With Quantra® System
	Completed	`NCT02775773` - Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH	Phase 3
	Completed	`NCT02216383` - Intramuscular Oxytocics: A Randomised Control Trial	Phase 3
	Completed	`NCT01571323` - Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean Section	Phase 1/Phase 2
	Terminated	`NCT02900690` - Health Economics Evaluation of the Management of Severe Postpartum Hemorrhage: Comparison of Recombinant Activated Factor VII Strategy to the Reference Strategy